Progression of chronic kidney disease: Insights from animal models

Current Opinion in Nephrology and Hypertension

Volumn 15, Issue 3, 2006, Pages 250-257

  Zoja, Carla ^a   Abbate, Mauro ^a   Remuzzi, Giuseppe ^a,b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b OSPEDALI RIUNITI   (Italy)

Author keywords

Fibrosis; Glomerulosclerosis; Podocyte; Proteinuria; Tubulointerstitial damage

Indexed keywords

ALPHA ACTININ; CD2 ASSOCIATED PROTEIN; CHEMOKINE RECEPTOR CCR1; CONNECTIVE TISSUE GROWTH FACTOR; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN LINKED KINASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEPHRIN; PODOCIN; RANTES;

CELL ACTIVATION; CELL DAMAGE; CELL FUNCTION; CHRONIC KIDNEY DISEASE; DISEASE COURSE; DISEASE MODEL; FIBROGENESIS; GENE TARGETING; GLOMERULOSCLEROSIS; GLOMERULUS BASEMENT MEMBRANE; HUMAN; INFLAMMATORY CELL; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY SCAR; KIDNEY TUBULE CELL; MYOFIBROBLAST; NONHUMAN; PATHOPHYSIOLOGY; PODOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEINURIA; REVIEW; T LYMPHOCYTE; TRANSGENIC ANIMAL;

ANIMALS; DISEASE PROGRESSION; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY GLOMERULUS; MEMBRANE PROTEINS; MODELS, ANIMAL; PODOCYTES;

EID: 33646813632     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mnh.0000222691.53970.83     Document Type: Review

References (57)

1. Anderson S, Meyer TW, Rennke HG, Brenner BM. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985; 76:612-619.
2. Kim YH, Goyal M, Kurnit D, et al. Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int 2001; 60:957-968.
3. White KE, Bilous RW, Marshall SM, et al. Podocyte number in normotensive type 1 diabetic patients with albuminuria. Diabetes 2002; 51:3083-3089.
4. Pagtalunan ME, Miller PL, Jumping-Eagle S, et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997; 99:342-348.
5. Lemley KV, Lafayette RA, Safai M, et al. Podocytopenia and disease severity in IgA nephropathy. Kidney Int 2002; 61:1475-1485.
6. Matsusaka T, Xin J, Niwa S, et al. Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury. J Am Soc Nephrol 2005; 16:1013-1023. An innovative study addressing directly the role of podocyte injury in the development of glomerulosclerosis in transgenic mice. Selective immunotoxin-induced damage to podocytes expressing human CD25 generates a model in which onset and severity of sclerosis can be monitored and manipulated to study specific gene function in podocytes.
7. Asano T, Niimura F, Pastan I, et al. Permanent genetic tagging of podocytes: fate of injured podocytes in a mouse model of glomerular sclerosis. J Am Soc Nephrol 2005; 16:2257-2262. True loss of podocytes was identified independently of the confounding effect of dedifferentiation or loss of specific markers. Results are also in support of a role of proliferation of parietal epithelial cells in the formation of the sclerotic lesion.
8. Wharram BL, Goyal M, Wiggins JE, et al. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 2005; 16:2941-2952. This is an important study that describes a novel model of glomerulosclerosis and provides major insight on the role of podocyte injury and depletion.
9. Wiggins JE, Goyal M, Sanden SK, et al. Podocyte hypertrophy, 'adaptation,' and 'decompensation' associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction. J Am Soc Nephrol 2005; 16:2953-2966. The results of this study show that podocyte hypertrophy above a certain threshold is associated with podocyte stress and then failure, ultimately responsible for the development of sclerotic lesions of aging rats.
10. Macconi D, Bonomelli M, Benigni A, et al. Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury. Am J Pathol 2006; 168:42-54.
11. Yu D, Petermann A, Kunter U, et al. Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. J Am Soc Nephrol 2005; 16:1733-1741.
12. Roselli S, Heidet L, Sich M, et al. Early glomerular filtration defect and severe renal disease in podocin-deficient mice. Mol Cell Biol 2004; 24:550-560.
13. Hirabayashi S, Mori H, Kansaku A, et al. MAGI-1 is a component of the glomerular slit diaphragm that is tightly associated with nephrin. Lab Invest 2005; 85:1528-1543.
14. Jones N, Eremina V, Blasutig IM, et al. The Nck adaptor protein associates with nephrin and is required for maintenance of the actin cytoskeleton in podocytes. J Am Soc Nephrol 2005; 16:107A.
15. Nicholas SB, Kim J, Collins AR, et al. Podocyte-specific β1-integrin knockout mouse develops significant albuminuria and early mortality [abstract]. J Am Soc Nephrol 2005; 16:432A. The first demonstration that the disruption of podocyte anchoring to the GBM, namely in knockout mice lacking β1-integrin in this cell type, leads to proteinuria, progressive tubulointerstitial damage, and glomerulosclerosis.
16. Kretzler M, Teixeira VP, Unschuld PG, et al. Integrin-linked kinase as a candidate downstream effector in proteinuria. Faseb J 2001; 15:1843-1845.
17. Teixeira Vde P, Blattner SM, Li M, et al. Functional consequences of integrin-linked kinase activation in podocyte damage. Kidney Int 2005; 67:514-523. In-vivo and in-vitro studies show a role for integrin-linked kinase-mediated mechanisms leading to podocyte detachment and repression of slit membrane molecules relevant to progressive glomerular injury.
18. Dai C, Stolz DB, Bastacky SI, et al. Essential role of integrin-linked kinase in podocyte biology: bridging the integrin and slit diaphragm signaling [abstract]. J Am Soc Nephrol 2005; 16:107A.
19. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998; 339:1448-1456.
20. Abbate M, Zoja C, Morigi M, et al. Transforming growth factor-β1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins. Am J Pathol 2002; 161:2179-2193.
21. Benigni A, Corna D, Zoja C, et al. Targeted deletion of angiotensin II type 1A receptor does not protect mice from progressive nephropathy of overload proteinuria. J Am Soc Nephrol 2004; 15:2666-2674.
22. Kamijo A, Sugaya T, Hikawa A, et al. Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules. Am J Pathol 2004; 165:1243-1255.
23. Abbate M, Zoja C, Corna D, et al. In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation. J Am Soc Nephrol 1998; 9:1213-1224.
24. Donadelli R, Abbate M, Zanchi C, et al. Protein traffic activates NF-κB gene signaling and promotes MCP-1-dependent interstitial inflammation. Am J Kidney Dis 2000; 36:1226-1241.
25. Wang Y, Chen J, Chen L, et al. Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. J Am Soc Nephrol 1997; 8:1537-1545.
26. Zoja C, Donadelli R, Colleoni S, et al. Protein overload stimulates RANTES production by proximal tubular cells depending on NF-κB activation. Kidney Int 1998; 53:1608-1615.
27. Tang S, Leung JCK. Abe K, et al. Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo. J Clin Invest 2003; 111:515-527.
28. Donadelli R, Zanchi C, Morigi M, et al. Protein overload induces fractalkine upregulation in proximal tubular cells through nuclear factor kappaB- and p38 mitogen-activated protein kinase-dependent pathways. J Am Soc Nephrol 2003; 14:2436-2446.
29. Takase O, Hirahashi J, Takayanagi A, et al. Gene transfer of truncated IkBa prevents tubulointerstitial injury. Kidney Int 2003; 63:501-513.
30. Vielhauer V, Berning E, Eis V, et al. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome. Kidney Int 2004; 66:2264-2278. Treatment with an antagonist of CCR1 receptor for MIP-1a and RANTES was beneficial against tubulointerstitial injury, in the presence of persistent proteinuria and glomerulopathy in mice with adriamycin nephrosis.
31. Shimizu H, Maruyama S, Yuzawa Y, et al. Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria. J Am Soc Nephrol 2003; 14:1496-1505.
32. Wu H, Wang Y, Tay YC, et al. DNA vaccination with naked DNA encoding MCP-1 and RANTES protects against renal injury in adriamycin nephropathy. Kidney Int 2005; 67:2178-2186. An innovative strategy using DNA vaccination to protect the kidney against chemokine-dependent injury.
33. Bonegio RG, Fuhro R, Wang Z, et al. Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy. J Am Soc Nephrol 2005; 16:2063-2072. Rapamycin is suggested in this study as an additional intervention to slowing proteinuria-associated tubulointerstitial injury.
34. Abbate M, Zoja C, Rottoli D, et al. Proximal tubular cells promote fibrogenesis by TGF-b1-mediated induction of peritubular myofibroblasts. Kidney Int 2002; 61:2066-2077.
35. Faulkner JL, Szcykalski LM, Springer F, Barnes JL. Origin of interstitial fibroblasts in an accelerated model of angiotensin II-induced renal fibrosis. Am J Pathol 2005; 167:1193-1205. A careful study further characterizing the interstitial fibroblast as a major cellular player in early stage of renal fibrosis.
36. Okada H, Kikuta T, Kobayashi T, et al. Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis. J Am Soc Nephrol 2005; 16:133-143. This paper provides important insight into the role of CTGF in renal fibrogenesis.
37. Quigg RJ. Complement and the kidney. J Immunol 2003; 171:3319-3324.
38. Abe K, Li K, Sacks SH, Sheerin NS. The membrane attack complex, C5b-9, up regulates collagen gene expression in renal tubular epithelial cells. Clin Exp Immunol 2004; 136:60-66.
39. Nath KA, Hostetter MK, Hostetter TH. Pathophysiology of chronic tubulointerstitial disease in rats: interactions of dietary acid load, ammonia, and complement component C3. J Clin Invest 1985; 76:667-675.
40. Eddy AA. Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol 1989; 135:719-733.
41. Nomura A, Morita Y, Maruyama S, et al. Role of complement in acute tubulointerstitial injury of rats with aminonucleoside nephrosis. Am J Pathol 1997; 151:539-547.
42. Abbate M, Zoja C, Rottoli D, et al. Antiproteinuric therapy while preventing the abnormal protein traffic in proximal tubule abrogates protein and complement-dependent interstitial inflammation in experimental renal disease. J Am Soc Nephrol 1999; 10:804-813.
43. Morita Y, Nomura A, Yuzawa Y, et al. The role of complement in the pathogenesis of tubulointerstitial lesions in rat mesangial proliferative glomerulonephritis. J Am Soc Nephrol 1997; 8:1363-1372.
44. Nangaku M, Pippin J, Couser WG. Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome. J Am Soc Nephrol 1999; 10:2323-2331.
45. Nangaku M, Pippin J, Couser WG. C6 mediates chronic progression of tubulointerstitial damage in rats with remnant kidneys. J Am Soc Nephrol 2002; 13:928-936.
46. Rangan GK, Pippin JW, Coombes JD, Couser WG. C5b-9 does not mediate chronic tubulointerstitial disease in the absence of proteinuria. Kidney Int 2005; 67:492-503.
47. He C, Imai M, Song H, et al. Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9. J Immunol 2005; 174:5750-5757. An original approach to investigate the role of MAC in proteinuria-induced tubulointerstitial injury. The study shows that systemically administered complement inhibitory molecules can be delivered selectively to the proximal tubule to attenuate renal injury associated with proteinuria.
48. Pratt JR, Basheer SA, Sacks SH. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 2002; 8:582-587.
49. Abbate M, Corna D, Rottoli D, et al. An intact complement pathway is not dispensable for glomerular and tubulointerstitial injury induced by protein overload [abstract]. J Am Soc Nephrol 2004; 15:479A.
50. Ikezumi Y, Kanno K, Karasawa T, et al. The role of lymphocytes in the experimental progressive glomerulonephritis. Kidney Int 2004; 66:1036-1048.
51. Peters H, Martini S, Wang Y, et al. Selective lymphocyte inhibition by FTY720 slows the progressive course of chronic anti-thy 1 glomerulosclerosis. Kidney Int 2004; 66:1434-1443. This study provides significant evidence that lymphocytes actively participate in the progression of renal damage in chronic anti-thy1.1 disease.
52. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22:531-562.
53. + lymphocytes of autoantigen-specific T-cell responses in Goodpasture's (anti-GBM) disease. Kidney Int 2003; 64:1685-1694.
54. Lindley S, Dayan CM, Bishop A, et al. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 2005; 54:92-99.
55. + T cells in human kidney transplant recipients. J Am Soc Nephrol 2003; 14:1643-1651.
56. + regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice. J Am Soc Nephrol 2005; 16:1360-1370.
57. + Immunoregulatory T cells suppress macrophage activation in vitro and prevent tissue injury in a lymphocyte-independent model of adriamycin nephropathy [abstract]. J Am Soc Nephrol 2005; 16:27A.